A Study to Evaluate the Effect of Food and Proton Pump Inhibitor on the Pharmacokinetics of ZN-A-1041 in Healthy Participants

Inclusion Criteria: * Body mass index (BMI) within the range of 18 to 32 kg/m2, inclusive * In good health, determined by no clinically significant findings from medical history, physical examination, 12-lead ECG, and vital signs, as determined by the investigator, at Screening and Check-in, as applicable * Clinical laboratory evaluations (including chemistry panel, CBC, and UA with complete microscopic analysis) within the normal reference ranges for the certified test laboratory at Screening and Check-in * Negative test for selected drugs of abuse at Screening and Check-in (includes alcohol) * Negative hepatitis panel (hepatitis B surface antigen, hepatitis B core antibody, hepatitis B surface antibody \[unless consistent with vaccination or immunity due to natural infection\], and hepatitis C virus antibody) and negative HIV antibody screens * For women of childbearing potential: agreement to remain abstinent or use contraception * For men: agreement to remain abstinent or use contraceptive methods, and agreement to refrain from donating sperm * Negative screening test for latent Mycobacterium tuberculosis infection * Able to swallow and retain multiple tablets without chewing or crushing * Able to consume the high-fat meal within the protocol-specified time period and willing to consume 100% of the high-fat meal * Able to fast for 8 hours prior to dosing Exclusion Criteria: * Significant history or clinical manifestation of any metabolic, allergic, dermatological, hepa…